Scott Hirsch -- Credit Suisse

Did you say that you have an agreement with the FDA on Remoxy going forward, or is this really just an understanding together for what needs to be done? And then, secondly, have you moved the old Alpharma Oxy NT product into phase 3 ready position?

Brian Markison

Yes, Scott. The answer to your second question is, not yet. The answer to your first question is that King and the FDA are exactly on the same page with regard to the steps that are necessary for the positive resubmission of Remoxy. And so we’re absolutely on the same page. That's the only way to describe it.